DJIA 17,778.15 421.28 2.43%
NASDAQ 4,748.40 104.08 2.24%
S&P 500 2,061.23 48.34 2.40%
market minute promo

ZIOPHARM Oncology (NASDAQ: ZIOP)

4.27 0.03 (0.71%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ZIOP $4.27 0.71%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $4.32
Previous Close $4.24
Daily Range $4.20 - $4.36
52-Week Range $2.31 - $5.58
Market Cap $438.6M
P/E Ratio -14.62
Dividend (Yield) $0.00 (0.0%)
Volume 663,077
Average Daily Volume 942,968
Current FY EPS -$0.40

Sector

Healthcare

Industry

Drugs

ZIOPHARM Oncology (ZIOP) Description

ZIOPHARM Oncology Inc. is a biopharmaceutical company engaged in the development and commercialization of small molecule and synthetic biology approaches to new cancer therapies. Website: http://www.ziopharm.com/

News & Commentary Rss Feed

This Week in Biotech: PTC Therapeutics Surprises, Isis' Data Dazzles, and Provectus Sinks

Four positive clinical updates, a billion-dollar licensing deal, a surprising positive opinion for one company in the EU, and a rough NYSEArca debut for one biopharma are this week's top biotech stories.

Increased Earnings Estimates Seen for ZIOPHARM Oncology (ZIOP): Can It Move Higher? - Tale of the

Increased Earnings Estimates Seen for ZIOPHARM Oncology (ZIOP): Can It Move Higher? - Tale of the Tape

ZIOPHARM, Intrexon Offer Clinical, Preclinical Data from Immuno-Oncology Programs: Showed Anti-Cance

ZIOPHARM, Intrexon Offer Clinical, Preclinical Data from Immuno-Oncology Programs: Showed Anti-Cancer Activity, Planning Phase 1b/@ Trial AD-RTS-HIL-12 with Veledimex

ZIOPHARM Oncology (ZIOP) Is Strong On High Volume Today

Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

ZIOPHARM Oncology (ZIOP) Jumps: Stock Moves Up 8.5% - Tale of the Tape

ZIOPHARM Oncology (ZIOP) in Focus: Stock Rises 10.4% - Tale of the Tape

Week In Review: PW Medtech Pays $130 Million For Fellow China Medical Device Company

Who Will Be Swimming Naked When The Tide Goes Out? (Part IV)

Ziopharm: Pipeline Expansion And Data Updates To Drive Near-Term Upside

Ziopharm Joins The CAR Crowd

See More ZIOP News...

ZIOP's Top Competitors

ZIOP $4.27 (0.71%)
Current stock: ZIOP
AMGN $168.48 (3.06%)
Current stock: AMGN
GILD $105.54 (3.07%)
Current stock: GILD
BIIB $353.70 (6.25%)
Current stock: BIIB